Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1/Phase 2

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera

Urmila DIwekar · with IVF Academy of USA, Positivf Fertility · NCT07148999

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 20–50 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Phase 1, Phase 2
Target enrollment
200
US sites recruiting
2
Study start
September 23, 2025
Record last updated
September 29, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

A clinical trial will determine the effectiveness of using the Opt-IVF decision support tool for each patient's personalized and optimal drug dosage profile in the United States.

Being studied: Opt-IVF; Control

Conditions: Infertility (IVF Patients)

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • infertile women

Exclusion Criteria

All female patients who will not undergo IVF or whose cycles will be converted to IUI. Male patients will not be enrolled in this study. No donor cycles.

Recruiting US locations

  • Positivf Fertility

    Houston, TX 77054

    Site contact: Paul Magarelli, MD, Ph.D. · 719-331-6392 · pcmagarelli@gmail.com

  • Positivf Fertility

    San Antonio, TX 78249

    Site contact: Francisco Arrendendo, MD, MPh · 210-404-2229 · paco@positivf.com

Study contacts (from the official record)

  • Urmila Diwekar, Ph.D. · 6308863047 · urmila@vri-custom.org
  • Sanjay Joag, M.D., Ph.D. · 6305014451 · sanjay@opt-ivf.com
All women’s health studies in Texas →
An Advanced Decision Support Tool for Personalized Medicine for… (NCT07148999) | Bored Studies